We’re delighted to add our latest Educational Series on cognitive impairment in patients with schizophrenia.
The review covers the background and burden of schizophrenia, schizophrenia and cognitive function, current management and treatments for cognitive impairment, and a focus on new glycine transporter-1 inhibitors. It also includes guiding commentary from Professor Malcolm Hopwood, Ramsay Health Care Professor of Psychiatry, at the University of Melbourne.
Please login below to download this issue (PDF)